A New Apheresis Device for Antithrombotic Drug Removal during Off-Pump Coronary Artery Bypass Surgery

Background and Objectives: The hemoadsorption device CytoSorb(®) (CytoSorbents Inc., Princeton, NJ, USA) has been shown to efficiently remove ticagrelor from whole blood in vitro. A promising clinical experience was made with the integration of the hemoadsorption cartridge on the cardiopulmonary byp...

Descripción completa

Detalles Bibliográficos
Autores principales: Mair, Helmut, Micka, Norman, Vogt, Ferdinand, Rosenzweig, Dow, Vogel, Frank, Baumer, Benedikt, Ulrich, Stephanie, Lamm, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Technical Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609020/
https://www.ncbi.nlm.nih.gov/pubmed/36295587
http://dx.doi.org/10.3390/medicina58101427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609020/
https://www.ncbi.nlm.nih.gov/pubmed/36295587
http://dx.doi.org/10.3390/medicina58101427

Ejemplares similares